Overview
- An international review reported by Becker’s found TrumpRx prices often exceed those paid in Germany, including a $2,700‑per‑month gap for the hormone therapy Ngenla.
- Usage remains muted per KFF data, with about one‑third of prescription takers aware of TrumpRx and 7% having visited the site, rising to 16% among GLP‑1 users.
- The platform operates like existing coupon services and relies on GoodRx’s network data, offers cash prices only, and purchases do not count toward insurance deductibles.
- Experts note most listings are brand‑name drugs and many have cheaper generics, limiting value for most insured patients and narrowing benefits to uninsured or high‑deductible users.
- The White House says more drugs will be added and it hopes to work with Congress to formalize deals, yet there is no sign of legislative movement and some pharmacies are declining the coupons.